|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Abbott inaugurates first nutrition R&D centre in India along with Syngene
|
|
Wednesday, 06 June, 2012, 08 : 00 AM [IST]
|
|
Our Bureau, Mumbai
|
|
fiogf49gjkf0d Abbott, one of India's leading healthcare companies, on Monday inaugurated its first nutrition research and development centre in the country, in collaboration with Syngene, India's leading contract research organisation. The centre was inaugurated by Dr Sam Pitroda, advisor to the Prime Minister of India on Public Information Infrastructure & Innovations and chairman of the National Innovation Council.
The state-of-the-art R&D centre will focus on the development of science-based, affordable nutrition products for the country and enable the expansion of Abbott's nutrition product portfolio. The facility will extend to over 13.000 sq ft and house a range of integrated capabilities including product development and analytical laboratories as well as a dedicated laboratory for analysing flavour, sensory elements and packaging. The analytical lab will be equipped with technology for a broad spectrum of nutritional analysis ranging from micronutrient to microbiological testing.
Abbott selected Syngene – a subsidiary of Biocon Group, the largest biotech company in India – to provide a science-based research and innovation team to work closely with Abbott researchers. More than 50 researchers and scientists will be based at the Abbott Nutrition R&D Center in India at Biocon Park in Bangalore.
The new R&D centre will focus on the development of nutrition products for maternal and child nutrition and diabetes care. The centre will tap into local expertise to focus on product design, development and delivery specifically for the Indian consumer market. Among the products being developed for the Indian market are meal complements for diabetics and pre-diabetics. In addition, the centre will address local taste and texture preferences with new flavours and formulations.
Speaking at the inauguration, John Landgraf, executive VP, Global Nutrition, Abbott, said, "Abbott’s scientific heritage has driven the growth of our company, which has been in India for over 100 years. This new R&D centre in Bangalore will play a pivotal role in getting us even closer to the Indian market and addressing the nutritional requirements of the Indian consumer."
"India is a priority market for investment, growth and innovation," said Robert H Miller, divisional VP, global R&D and scientific affairs, Abbott Nutrition. "Our strategic collaboration with Syngene will accelerate the design, development and delivery of science-based, affordable nutrition products in India, for India."
The nutrition market in India is relatively new and growing steadily. In addition to the undernutrition and diabetes issues facing India, a rapidly expanding middle class and ageing population are driving increased demand in the country for high-quality, affordable nutrition products.
“It’s a landmark day for Abbott Nutrition and Syngene, as they shape their common vision of innovating towards a healthier India through affordable nutrition products," said Kiran Mazumdar Shaw, CMD, Biocon Group. "The combined market insights and nutrition science expertise of our two organisations will enable us to address the healthcare and nutritional challenges of an emerging economy like India across a diverse range of diseases that straddle both infectious and chronic maladies," she added.
Commenting on the collaboration, Peter Bains, director, Syngene International Ltd, said, "We are delighted that Syngene’s discovery scientists and development capabilities will be supporting Abbott Nutrition in this important strategic initiative in India.”
|
|
|
|
|
|
|
|
|
|